期刊
MEDICINAL CHEMISTRY RESEARCH
卷 24, 期 3, 页码 1189-1195出版社
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-014-1206-7
关键词
Polyion complex; Nano-prodrug; Controlled release; Anti-cancer drug
资金
- Science and Technology Support Program of Jiangsu Province [BE2012017]
- State Key Laboratory of Hydrology-Water Resources, and Hydraulic Engineering, Hohai University [2012490911]
A polyion complex nano-prodrug based on the complexation of the ionomer of poly(lactic acid-co-malic acid)-block-polyethylene glycol [Poly(LA-co-MA)-b-PEG] with doxorubicin (DOX) was developed. The ionomer was prepared by a direct polycondensation of d,l-lactic acid (LA), l-malic acid (MA), and monomethyl polyethylene glycol (PEG) using stannous chloride (SnCl2) as the catalyst. The nanoparticles were formed through electrostatic interactions between the side carboxyl groups of MA units in the ionomer and amino groups of DOX. The nanoparticle possessed an amphiphilic structure with a hydrophobic core of the complexed DOX and Poly(LA-co-MA) and a hydrophilic shell of PEG. The nanoparticle solution was stable, and the particle sizes were in the range of 110-140 nm. The DOX was loaded as a prodrug with loading rate as high as 18.2 %. The drug release could be controlled, showing responsiveness of acids and ionic strength. The cumulative release was as high as 94 %. The nanoparticles could be potentially used as anti-cancer drug vehicles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据